Citations (123)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
C.-G. Af Björkesten, A. Jussila, H. Kemppainen, T. Hallinen, E. Soini, P. Mankinen, S. Valgarðsson, V. Veckman, R. Nissinen, D. Naessens & P. Molander. (2019) Relationship of faecal calprotectin and long-term outcomes in Finnish patients with Crohn’s disease: retrospective multi-centre chart review study. Scandinavian Journal of Gastroenterology 54:10, pages 1226-1232.
Read now
Read now
Johanna Engström, Maria Lönnkvist, Ragnar Befrits, Tryggve Ljung, Hetzel Diaz-Tartera, Mikael Holst & Per M. Hellström. (2019) Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy. Scandinavian Journal of Gastroenterology 54:9, pages 1081-1088.
Read now
Read now
Anja Eberl, Taru Hallinen, Clas-Göran af Björkesten, Markku Heikkinen, Eija Hirsi, Mikko Kellokumpu, Inka Koskinen, Veikko Moilanen, Christian Nielsen, Heikki Nuutinen, Ulla-Maija Suhonen, Karri Utriainen, Ilkka Vihriälä, Erkki Soini, Christina Wennerström, Riikka Nissinen, Andras Borsi, Minni Koivunen, Jyrki Tillonen & Taina Sipponen. (2019) Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE). Scandinavian Journal of Gastroenterology 54:6, pages 718-725.
Read now
Read now
Sara Monteiro, Francisca Dias de Castro, Sílvia Leite, Maria João Moreira & José Cotter. (2019) Low fecal calprotectin predicts clinical remission in Crohn's disease patients: the simple answer to a challenging question. Scandinavian Journal of Gastroenterology 54:1, pages 49-54.
Read now
Read now
Károly Palatka, Sándor Kacska, Szilvia Lovas, Ildikó Garai, József Varga & László Galuska. (2018) The potential role of FDG PET-CT in the characterization of the activity of Crohn’s disease, staging follow-up and prognosis estimation: a pilot study. Scandinavian Journal of Gastroenterology 53:1, pages 24-30.
Read now
Read now
Carl Eriksson, Jan Marsal, Daniel Bergemalm, Lina Vigren, Jan Björk, Michael Eberhardson, Pontus Karling, Charlotte Söderman, Pär Myrelid, Yang Cao, Daniel Sjöberg, Mari Thörn, Per Karlén, Erik Hertervig, Hans Strid, Jonas F. Ludvigsson, Sven Almer & Jonas Halfvarson. (2017) Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). Scandinavian Journal of Gastroenterology 52:6-7, pages 722-729.
Read now
Read now
Vendel Kristensen, Gunn Helen Malmstrøm, Viggo Skar, Arne Røseth & Bjørn Moum. (2016) Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure. Scandinavian Journal of Gastroenterology 51:5, pages 548-555.
Read now
Read now
Vendel Kristensen, Trine Lauritzen, Lars-Petter Jelsness-JØrgensen & BjØrn Moum. (2015) Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods. Scandinavian Journal of Clinical and Laboratory Investigation 75:5, pages 355-361.
Read now
Read now
Krisztina B. Gecse, Johannan F. Brandse, Sandra van Wilpe, Mark Löwenberg, Cyriel Ponsioen, Gijs van den Brink & Geert D’Haens. (2015) Impact of disease location on fecal calprotectin levels in Crohn’s disease. Scandinavian Journal of Gastroenterology 50:7, pages 841-847.
Read now
Read now
Taina Sipponen & Kaija-Leena Kolho. (2015) Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 74-80.
Read now
Read now
Vladimir Stanisic & Eamonn MM Quigley. (2014) The overlap between IBS and IBD – what is it and what does it mean?. Expert Review of Gastroenterology & Hepatology 8:2, pages 139-145.
Read now
Read now
Clas-Göran af Björkesten, Urpo Nieminen, Taina Sipponen, Ulla Turunen, Perttu Arkkila & Martti Färkkilä. (2013) Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease. Scandinavian Journal of Gastroenterology 48:5, pages 543-551.
Read now
Read now
Roberta Caccaro, Renata D’Incà, Surajit Pathak & Giacomo Carlo Sturniolo. (2012) Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?. Expert Review of Clinical Immunology 8:6, pages 579-585.
Read now
Read now
Sophie Vieujean, Romain Gillard, Pierre Delanaye, Laurence Seidel, Emeline Bequet, Catherine Salée, Marie-Alice Meuwis, Charlotte Massot, Nicolas Pierre, Paul Meunier, Etienne Cavalier & Edouard Louis. Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn’s disease. Scandinavian Journal of Gastroenterology 0:0, pages 1-8.
Read now
Read now
Articles from other publishers (109)
Xiaolin Hu, Jiajia Li, Yunyun Sun, Dacheng Wu, Tiantian Zhao, Maofeng Ma, Jie Chen, Mei Wang & Sicong Hou. (2023) Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn’s disease. BMC Gastroenterology 23:1.
Crossref
Crossref
Emily Brownson, Jayne Saunders, Aleksandra Jatkowska, Bernadette White, Konstantinos Gerasimidis, John Paul Seenan & Jonathan Macdonald. (2023) Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy. Inflammatory Bowel Diseases.
Crossref
Crossref
Marta Freitas, Francisca Dias de Castro, Vítor Macedo Silva, Cátia Arieira, Tiago Cúrdia Gonçalves, Sílvia Leite, Maria João Moreira & José Cotter. (2023) Reply to comment on “Ultrasonographic scores for ileal Crohn’s disease assessment: better, worse or the same as contrast‑enhanced ultrasound?. BMC Gastroenterology 23:1.
Crossref
Crossref
Anuj Bohra, Ghada Mohamed, Abhinav Vasudevan, Diana Lewis, Daniel R. Van Langenberg & Jonathan P. Segal. (2023) The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines 11:5, pages 1408.
Crossref
Crossref
Lidia Neamți, Tudor Drugan, Cristina Drugan, Ciprian Silaghi, Lidia Ciobanu & Alexandra Crăciun. (2023) An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease—A Pilot Study. Journal of Clinical Medicine 12:4, pages 1663.
Crossref
Crossref
Tatsuya Kawamura, Takeshi Yamamura, Masanao Nakamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Tadashi Iida, Yasuyuki Mizutani, Takuya Ishikawa, Naomi Kakushima, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima & Masatoshi Ishigami. (2023) Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn’s Disease. Inflammatory Bowel Diseases 29:2, pages 245-253.
Crossref
Crossref
Xiaojun Li, Lamei Yan, Xuehong Wang, Chunhui Ouyang, Chunlian Wang, Jun Chao, Jie Zhang & Guanghui Lian. (2022) Predictive models for endoscopic disease activity in patients with ulcerative colitis: Practical machine learning-based modeling and interpretation. Frontiers in Medicine 9.
Crossref
Crossref
Floris De Voogd, Harshad Joshi, Elsa Van Wassenaer, Steven Bots, Geert D’Haens & Krisztina Gecse. (2022) Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 28:7, pages 1045-1052.
Crossref
Crossref
Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman & Jan Marsal. (2022) Real‐world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 55:11, pages 1389-1401.
Crossref
Crossref
Rebecca L. Smith, Kirstin M. Taylor, Antony B. Friedman, David J. Gibson, Danny Con & Peter R. Gibson. (2022) Early sonographic response to a new medical therapy is associated with future treatment response or failure in patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 34:6, pages 613-621.
Crossref
Crossref
M. Freitas, F. Dias de Castro, V. Macedo Silva, C. Arieira, T. Cúrdia Gonçalves, S. Leite, M. J. Moreira & J. Cotter. (2022) Ultrasonographic scores for ileal Crohn’s disease assessment: Better, worse or the same as contrast-enhanced ultrasound?. BMC Gastroenterology 22:1.
Crossref
Crossref
Matthew D Coates & David G Binion. (2021) Silent Inflammatory Bowel Disease. Crohn's & Colitis 360 3:3.
Crossref
Crossref
Rebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib, Katri Korpela, Seppo Virtanen, Taina Sipponen, Anne Salonen, Päivi Saavalainen & Eija Nissilä. (2021) Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 15:6, pages 1019-1031.
Crossref
Crossref
Anthony Buisson, Wing Yan Mak, Michael J AndersenJrJr, Donald Lei, Joel Pekow, Russell D Cohen, Stacy A Kahn, Bruno Pereira & David T Rubin. (2021) Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn’s Disease Regardless of Disease Location. Inflammatory Bowel Diseases 27:7, pages 1008-1016.
Crossref
Crossref
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński & Małgorzata Krzystek-Korpacka. (2021) Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 10:10, pages 2203.
Crossref
Crossref
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara & Maria de Lourdes A. Ferrari. (2021) Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease. Gastroenterología y Hepatología 44:2, pages 87-95.
Crossref
Crossref
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara & Maria de Lourdes A. Ferrari. (2021) Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease. Gastroenterología y Hepatología (English Edition) 44:2, pages 87-95.
Crossref
Crossref
Vera Peters, Ettje F. Tigchelaar-Feenstra, Floris Imhann, Jackie A. M. Dekens, Morris A. Swertz, Lude H. Franke, Cisca Wijmenga, Rinse K. Weersma, Behrooz Z. Alizadeh, Gerard Dijkstra & Marjo J. E. Campmans-Kuijpers. (2020) Habitual dietary intake of IBD patients differs from population controls: a case–control study. European Journal of Nutrition 60:1, pages 345-356.
Crossref
Crossref
Pierre-Adrien Dalbiès, Jean-Marc Canard, Jean-Christophe Létard & Denis Sautereau. (2020) Le rôle de l’échographie digestive (ED) dans le suivi de la maladie de Crohn. Hegel N° 4:4, pages 300-309.
Crossref
Crossref
Clas-Göran af Björkesten, Tuire Ilus, Taru Hallinen, Erkki Soini, Anja Eberl, Kalle Hakala, Mikko Heikura, Airi Jussila, Ritva Koskela, Inka Koskinen, Veikko Moilanen, Christian Nielsen, Urpo Nieminen, Heikki Nuutinen, Markku Heikkinen, Ulla-Maija Suhonen, Jyrki Tillonen, Karri Utriainen, Ilkka Vihriälä, Christina Wennerström, Andras Borsi, Riikka Nissinen, Minni R. Koivunen & Taina Sipponen. (2020) Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort. European Journal of Gastroenterology & Hepatology 32:12, pages 1507-1513.
Crossref
Crossref
Bing Zhang, Alakh Gulati, Omeed Alipour & Ling Shao. (2020) Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 14:10, pages 1413-1423.
Crossref
Crossref
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke & Katarzyna Neubauer. (2020) Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 10:6, pages 367.
Crossref
Crossref
Shay Ehrlich, Anat Guz Mark, Firas Rinawi, Raanan Shamir & Amit Assa. (2019) Micronutrient Deficiencies in Children With Inflammatory Bowel Diseases. Nutrition in Clinical Practice 35:2, pages 315-322.
Crossref
Crossref
Friederike CordesClaudia DemmigArne BokemeyerMarkus BrücknerFrank LenzePhilipp LenzTobias NowackiPhil TepasseHartmut H. SchmidtM. Alexander SchmidtChristoph CichonDominik Bettenworth. (2020) MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 11:3, pages e00134.
Crossref
Crossref
Filippo Vernia, Mirko Di Ruscio, Gianpiero Stefanelli, Angelo Viscido, Giuseppe Frieri & Giovanni Latella. (2019) Is fecal calprotectin an accurate marker in the management of Crohn's disease?. Journal of Gastroenterology and Hepatology 35:3, pages 390-400.
Crossref
Crossref
Xiaoqin LinYun QiuRui FengBaili ChenYao HeZhirong ZengShenghong ZhangMinhu ChenRen Mao. (2020) Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission. Clinical and Translational Gastroenterology 11:2, pages e00135.
Crossref
Crossref
Parambir S. Dulai, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E. Sands, Axel Dignass, Dan Turner, Gerassimos Mantzaris, Juergen Schölmerich, Jean-Yves Mary, Walter Reinisch & William J. Sandborn. (2019) Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases. Gastroenterology 157:4, pages 1032-1043.e1.
Crossref
Crossref
Gianluca Galazzo, Danyta I Tedjo, Dion S J Wintjens, Paul H M Savelkoul, Ad A M Masclee, Alexander G L Bodelier, Marie J Pierik, Daisy M A E Jonkers & John Penders. (2019) Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease. Journal of Crohn's and Colitis 13:10, pages 1273-1282.
Crossref
Crossref
Emilio J. Laserna-Mendieta & Alfredo J. Lucendo. (2019) Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations. Clinical Chemistry and Laboratory Medicine (CCLM) 57:9, pages 1295-1307.
Crossref
Crossref
Kathryn A Sexton, John R Walker, Laura E Targownik, Lesley A Graff, Clove Haviva, Brooke E Beatie, Sarah K Petty, Matthew T Bernstein, Harminder Singh, Norine Miller & Charles N Bernstein. (2019) The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application. Inflammatory Bowel Diseases 25:8, pages 1277-1290.
Crossref
Crossref
Wenbin Gong, Kun Guo, Tao Zheng, Miao Fang, Haohao Xie, Weijie Li, Zhiwu Hong, Huajian Ren, Guosheng Gu, Gefei Wang, Xiuwen Wu, Zhiming Wang, Jianan Ren & Jieshou Li. (2019) Correlation between endoscopic and histological validated scoring indices in Crohn’s disease. Digestive and Liver Disease 51:6, pages 812-817.
Crossref
Crossref
Prianka Gajula & Eamonn M. Quigley. (2019) Overlapping irritable bowel syndrome and inflammatory bowel disease. Minerva Gastroenterologica e Dietologica 65:2.
Crossref
Crossref
Ebby George Simon, Richard Wardle, Aye Aye Thi, Jeanette Eldridge, Sunil Samuel & Gordon William Moran. (2019) Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review. Intestinal Research 17:2, pages 160-170.
Crossref
Crossref
Christian Maaser & Kerri Novak. 2019. Inflammatory Bowel Disease Nursing Manual. Inflammatory Bowel Disease Nursing Manual
51
60
.
Eugene Gonzalez-Lopez, Yuka Imamura Kawasawa, Vonn Walter, Lijun Zhang, Walter A. Koltun, Xuemei Huang, Kent E. Vrana & Matthew D. Coates. (2018) Homozygosity for the SCN10A Polymorphism rs6795970 Is Associated With Hypoalgesic Inflammatory Bowel Disease Phenotype. Frontiers in Medicine 5.
Crossref
Crossref
Inbar Weinstein-Nakar, Gili Focht, Peter Church, Thomas D. Walters, Guila Abitbol, Sudha Anupindi, Laureline Berteloot, Jessie M. Hulst, Frank Ruemmele, Daniel A. Lemberg, Steven T. Leach, Ruth Cytter, Mary-Louise Greer, Anne M. Griffiths & Dan Turner. (2018) Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn’s Disease. Clinical Gastroenterology and Hepatology 16:7, pages 1089-1097.e4.
Crossref
Crossref
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,Grażyna Rydzewska. (2018) Crohn’s disease activity evaluation based on imaging studies and biomarkers. Gastroenterology & Hepatology: Open Access 9:2.
Crossref
Crossref
Marcus A. Gray, Che-yung Chao, Heidi M. Staudacher, Natasha A. Kolosky, Nicholas J. Talley & Gerald Holtmann. (2018) Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases. PLOS ONE 13:3, pages e0193542.
Crossref
Crossref
Ahmed A. Almousa, Marc Morris, Sharyle Fowler, Jennifer Jones & Jane Alcorn. (2018) Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices. Clinical Biochemistry 53, pages 19-24.
Crossref
Crossref
Pierre Baillet, Guillaume Cadiot, Marion Goutte, Felix Goutorbe, Hedia Brixi, Christine Hoeffel, Christophe Allimant, Maud Reymond, Hélène Obritin-Guilhen, Benoit Magnin, Gilles Bommelaer, Bruno Pereira, Constance Hordonneau & Anthony Buisson. (2018) Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence. World Journal of Gastroenterology 24:5, pages 641-650.
Crossref
Crossref
Marc W Morris, Samuel A Stewart, Courtney Heisler, William J Sandborn, Edward V Loftus, Gordon A Zello, Sharyle A Fowler & Jennifer L Jones. (2018) Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity. Inflammatory Bowel Diseases 24:2, pages 277-285.
Crossref
Crossref
Phillip Minar, Kimberly Jackson, Yi-Ting Tsai, Heidi Sucharew, Michael J Rosen & Lee A Denson. (2018) Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn’s Disease. Inflammatory Bowel Diseases 24:1, pages 198-208.
Crossref
Crossref
Jin-Min Chen, Tao Liu, Shan Gao, Xu-Dong Tong, Fei-Hong Deng & Biao Nie. (2017) Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World Journal of Gastroenterology 23:46, pages 8235-8247.
Crossref
Crossref
Vipul Aggarwal, Andrew S. Day, Susan Connor, Steven T. Leach, Gregor Brown, Rajvinder Singh, Antony Friedman, Amany Zekry & Philip I. Craig. (2017) Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse. Gastrointestinal Endoscopy 86:6, pages 1070-1078.
Crossref
Crossref
Yan Epelboym, Paul B. Shyn, Jeffrey Forris Beecham Chick, Matthew J. Hamilton, Stacy D. O'Connor, Stuart G. Silverman & Chun K. Kim. (2017) Crohn Disease. Clinical Nuclear Medicine 42:11, pages 837-841.
Crossref
Crossref
Anna-Maija Puolanne, Kaija-Leena Kolho, Henrik Alfthan, Ari Ristimäki, Harri Mustonen & Martti Färkkilä. (2017) Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease. Digestive Diseases and Sciences 62:11, pages 3123-3130.
Crossref
Crossref
Felix Sommer, Malte Christoph Rühlemann, Corinna Bang, Marc Höppner, Ateequr Rehman, Christoph Kaleta, Phillippe Schmitt-Kopplin, Astrid Dempfle, Stephan Weidinger, Eva Ellinghaus, Susanne Krauss-Etschmann, Dirk Schmidt-Arras, Konrad Aden, Dominik Schulte, David Ellinghaus, Stefan Schreiber, Andreas Tholey, Jan Rupp, Matthias Laudes, John F Baines, Philip Rosenstiel & Andre Franke. (2017) Microbiomarkers in inflammatory bowel diseases: caveats come with caviar. Gut 66:10, pages 1734-1738.
Crossref
Crossref
Daniël R. Hoekman, Judith Zeevenhooven, Geert R. D’Haens & Marc A. Benninga. (2017) The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission. European Journal of Gastroenterology & Hepatology 29:9, pages 1086-1090.
Crossref
Crossref
James Turvill, Lisa Rook, Maxine Rawle, Gerry Robins, Simon Smale, Prashant Kant & Anne Phillips. (2017) Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's disease. Frontline Gastroenterology 8:3, pages 183-188.
Crossref
Crossref
William J. Sandborn, Douglas C. Wolf, Gordana Kosutic, Gerry Parker, Stefan Schreiber, Scott D. Lee, Bincy Abraham, Anita Afzali, Razvan I. Arsenescu, Alexandra Gutierrez, Marshall Spearman, Jason Coarse & Brian G. Feagan. (2017) Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol. Inflammatory Bowel Diseases 23:7, pages 1047-1056.
Crossref
Crossref
Marin de Jong, Andrea van der Meulen-de Jong, Mariëlle Romberg-Camps, Juliette Degens, Marco Becx, Tineke Markus, Henny Tomlow, Mia Cilissen, Nienke Ipenburg, Marthe Verwey, Laurence Colautti-Duijsens, Wim Hameeteman, Ad Masclee, Daisy Jonkers & Marieke Pierik. (2017) Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD. Inflammatory Bowel Diseases 23:4, pages 485-493.
Crossref
Crossref
Tim RA van den Heuvel, Daisy M Jonkers, Steven FG Jeuring, Marielle JL Romberg-Camps, Liekele E Oostenbrug, Maurice P Zeegers, Ad A Masclee & Marie J Pierik. (2017) Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL). International Journal of Epidemiology 46:2, pages e7-e7.
Crossref
Crossref
Tamer W. Kassem. (2017) Ileal Crohn's disease activity predicted by ruler: CT enterography histopathology correlation. The Egyptian Journal of Radiology and Nuclear Medicine 48:1, pages 7-13.
Crossref
Crossref
Alexander G. L. Bodelier, Daisy Jonkers, Tim van den Heuvel, Evelien de Boer, Wim Hameeteman, Ad A. M. Masclee & Marie J. Pierik. (2016) High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score. Digestive Diseases and Sciences 62:2, pages 465-472.
Crossref
Crossref
Juan María Vázquez Morón, Héctor Pallarés Manrique, Francisco H. Machancoses, Manuel Ramos Lora & Carlos Ruíz Frutos. (2017) Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohns disease with fecal calprotectin. Revista Española de Enfermedades Digestivas 109.
Crossref
Crossref
Rahul S. Dalal, Jan-Michael Klapproth & Gary R. Lichtenstein. 2017. Inflammatory Bowel Disease. Inflammatory Bowel Disease
147
182
.
Danyta. I. Tedjo, Agnieszka Smolinska, Paul H. Savelkoul, Ad A. Masclee, Frederik J. van Schooten, Marieke J. Pierik, John Penders & Daisy M. A. E. Jonkers. (2016) The fecal microbiota as a biomarker for disease activity in Crohn’s disease. Scientific Reports 6:1.
Crossref
Crossref
Rahul Kalla, Nicholas A Kennedy, Nicholas T Ventham, Ray K Boyapati, Alex T Adams, Elaine R Nimmo, Micaela R Visconti, Hazel Drummond, Gwo-Tzer Ho, Rebecca J Pattenden, David C Wilson & Jack Satsangi. (2016) Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. American Journal of Gastroenterology 111:12, pages 1796-1805.
Crossref
Crossref
Walter Reinisch, Jean-Frédéric Colombel, Geert D’Haens, William J. Sandborn, Paul Rutgeerts, Karel Geboes, Joel Petersson, Samantha Eichner, Qian Zhou, Anne M. Robinson, Holly A. Read & Roopal Thakkar. (2016) Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial. Journal of Crohn's and Colitis, pages jjw178.
Crossref
Crossref
Anna-Maija Puolanne, Kaija-Leena Kolho, Henrik Alfthan, Ari Ristimäki, Harri Mustonen & Martti Färkkilä. (2016) Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease. European Journal of Clinical Investigation 46:10, pages 825-832.
Crossref
Crossref
Marisa Iborra, Belén Beltrán & Pilar Nos. (2016) Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 26:4, pages 641-656.
Crossref
Crossref
Sasha Taleban, Emad Elquza, Corinne Gower-Rousseau & Laurent Peyrin-Biroulet. (2016) Cancer and inflammatory bowel disease in the elderly. Digestive and Liver Disease 48:10, pages 1105-1111.
Crossref
Crossref
L Vuitton, P Marteau, W J Sandborn, B G Levesque, B Feagan, S Vermeire, S Danese, G D'Haens, M Lowenberg, R Khanna, G Fiorino, S Travis, J Y Mary & L Peyrin-Biroulet. (2016) IOIBD technical review on endoscopic indices for Crohn's disease clinical trials. Gut 65:9, pages 1447-1455.
Crossref
Crossref
Sasha Taleban, Kathleen O. Stewart, Darrick K. Li, Prashant Singh, Darrell S. Pardi, Holly C. Sturgeon, Vijay Yajnik, Ramnik J. Xavier, Ashwin N. Ananthakrishnan & Hamed Khalili. (2016) Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn’s Disease Phenotypes. Digestive Diseases and Sciences 61:9, pages 2627-2635.
Crossref
Crossref
Reena Khanna, Sigrid A Nelson, Brian G Feagan, Geert D'Haens, William J Sandborn, GY Zou, John K MacDonald, Claire E Parker, Vipul Jairath & Barrett G Levesque. (2016) Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Cristiano Pagnini, Francesca Menasci, Federico Desideri, Vito D. Corleto, Gianfranco Delle Fave & Emilio Di Giulio. (2016) Endoscopic scores for inflammatory bowel disease in the era of ‘mucosal healing’: Old problem, new perspectives. Digestive and Liver Disease 48:7, pages 703-708.
Crossref
Crossref
Emily K. Wright, Michael A. Kamm, Peter De Cruz, Amy L. Hamilton, Kathryn J. Ritchie, Jacqueline I. Keenan, Steven Leach, Laura Burgess, Alan Aitchison, Alexandra Gorelik, Danny Liew, Andrew S. Day & Richard B. Gearry. (2016) Comparison of Fecal Inflammatory Markers in Crohnʼs Disease. Inflammatory Bowel Diseases 22:5, pages 1086-1094.
Crossref
Crossref
David J Gracie, Christopher J M Williams, Ruchit Sood, Saqib Mumtaz, Hassan M Bholah, John P Hamlin & Alexander C Ford. (2016) Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease. American Journal of Gastroenterology 111:4, pages 541-551.
Crossref
Crossref
Bella Ungar, Idan Levy, Yarden Yavne, Miri Yavzori, Orit Picard, Ella Fudim, Ronen Loebstein, Yehuda Chowers, Rami Eliakim, Uri Kopylov & Shomron Ben-Horin. (2016) Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 14:4, pages 550-557.e2.
Crossref
Crossref
Eamonn M. M. Quigley. (2015) Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?. Therapeutic Advances in Gastroenterology 9:2, pages 199-212.
Crossref
Crossref
Laurent Peyrin-Biroulet, Julián Panés, William J. Sandborn, Séverine Vermeire, Silvio Danese, Brian G. Feagan, Jean-Frédéric Colombel, Stephen B. Hanauer & Beth Rycroft. (2016) Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clinical Gastroenterology and Hepatology 14:3, pages 348-354.e17.
Crossref
Crossref
Peter Bossuyt & Séverine Vermeire. (2016) Treat to Target in Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 14:1, pages 61-72.
Crossref
Crossref
Alex Menys, Jesica Makanyanga, Andrew Plumb, Gauraang Bhatnagar, David Atkinson, Anton Emmanuel & Stuart A. Taylor. (2016) Aberrant Motility in Unaffected Small Bowel is Linked to Inflammatory Burden and Patient Symptoms in Crohnʼs Disease. Inflammatory Bowel Diseases 22:2, pages 424-432.
Crossref
Crossref
Vendel Kristensen, Trine Lauritzen, Lars-Petter Jelsness-Jørgensen, Svein Oskar Frigstad, Christian Corwin & Bjørn Moum. (2016) Patient-performed extraction of faecal calprotectin. Clinical Chemistry and Laboratory Medicine (CCLM) 54:8.
Crossref
Crossref
Krista M. Reich, Richard N. Fedorak, Karen Madsen & Karen I. Kroeker. (2016) Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohnʼs Disease. Inflammatory Bowel Diseases 22:1, pages 92-99.
Crossref
Crossref
N. Paquet, J.N. Glickman, S.M. Erturk, P.R. Ros, J.T. Heverhagen & M.A. Patak. (2016) Crohn’s disease Activity: Abdominal Computed Tomography Histopathology Correlation. European Journal of Radiology Open 3, pages 74-78.
Crossref
Crossref
Kerri Novak, Divine Tanyingoh, Frauke Petersen, Torsten Kucharzik, Remo Panaccione, Subrata Ghosh, Gilaad G. Kaplan, Alex Wilson, Klaus Kannengiesser & Christian Maaser. (2015) Clinic-based Point of Care Transabdominal Ultrasound for Monitoring Crohn’s Disease: Impact on Clinical Decision Making. Journal of Crohn's and Colitis 9:9, pages 795-801.
Crossref
Crossref
Alexander G. L. Bodelier, Agnieszka Smolinska, Agnieszka Baranska, Jan W. Dallinga, Zlatan Mujagic, Kimberly Vanhees, Tim van den Heuvel, Ad A. M. Masclee, Daisy Jonkers, Marie J. Pierik & Frederik J. van Schooten. (2015) Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohnʼs Disease. Inflammatory Bowel Diseases 21:8, pages 1776-1785.
Crossref
Crossref
Doron Yablecovitch, Assaf Stein, Maytal Shabat-Simon, Timna Naftali, Gila Gabay, Ido Laish, Asaf Oren & Fred M. Konikoff. (2015) Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 60:8, pages 2419-2426.
Crossref
Crossref
Mahmoud H Mosli, Guangyong Zou, Sushil K Garg, Sean G Feagan, John K MacDonald, Nilesh Chande, William J Sandborn & Brian G Feagan. (2015) C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 110:6, pages 802-819.
Crossref
Crossref
Antonio Tursi, Walter Elisei, Marcello Picchio, GianMarco Giorgetti & Giovanni Brandimarte. (2014) Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists. Digestive Diseases and Sciences 60:5, pages 1406-1413.
Crossref
Crossref
Vivian W. Huang, Connie Prosser, Karen I. Kroeker, Haili Wang, Carol Shalapay, Neil Dhami, Darryl K. Fedorak, Brendan Halloran, Levinus A. Dieleman, Karen J. Goodman & Richard N. Fedorak. (2015) Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
James D. Falvey, Teagan Hoskin, Berrie Meijer, Anna Ashcroft, Russell Walmsley, Andrew S. Day & Richard B. Gearry. (2015) Disease Activity Assessment in IBD. Inflammatory Bowel Diseases 21:4, pages 824-831.
Crossref
Crossref
Gudula JAM Boon. (2015) Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?. World Journal of Gastroenterology 21:40, pages 11469.
Crossref
Crossref
Shannon Chang. (2015) Disease monitoring in inflammatory bowel disease. World Journal of Gastroenterology 21:40, pages 11246.
Crossref
Crossref
Paul B. Stoddard, Leyla J. Ghazi, Jade Wong-You-Cheong, Raymond K. Cross & Fauzia Q. Vandermeer. (2015) Magnetic Resonance Enterography. Inflammatory Bowel Diseases 21:1, pages 229-239.
Crossref
Crossref
Barrett G. Levesque, William J. Sandborn, Joannie Ruel, Brian G. Feagan, Bruce E. Sands & Jean-Frederic Colombel. (2015) Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice. Gastroenterology 148:1, pages 37-51.e1.
Crossref
Crossref
Mark A. Samaan & Geert D’Haens. 2015. Endoscopy in Inflammatory Bowel Disease. Endoscopy in Inflammatory Bowel Disease
205
226
.
David B. Sachar. (2014) Role of Biomarkers in the Study and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2511-2518.
Crossref
Crossref
Luisa Guidi, Manuela Marzo, Gianluca Andrisani, Carla Felice, Daniela Pugliese, Giammarco Mocci, Olga Nardone, Italo De Vitis, Alfredo Papa, Gianlodovico Rapaccini, Franca Forni & Alessandro Armuzzi. (2014) Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. Digestive and Liver Disease 46:11, pages 974-979.
Crossref
Crossref
Reena Khanna, Guillaume Bouguen, Brian G. Feagan, Geert DʼHaens, William J. Sandborn, Elena Dubcenco, K. Adam Baker & Barrett G. Levesque. (2014) A Systematic Review of Measurement of Endoscopic Disease Activity and Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 20:10, pages 1850-1861.
Crossref
Crossref
Emilio Quaia, Biagio Cabibbo, Michele Sozzi, Antonio Giulio Gennari, Michele Pontello, Ferruccio Degrassi & Maria Assunta Cova. (2014) Biochemical Markers and MR Imaging Findings as Predictors of Crohn Disease Activity in Patients Scanned by Contrast-enhanced MR Enterography. Academic Radiology 21:10, pages 1225-1232.
Crossref
Crossref
Emily K. Wright, Peter De Cruz, Richard Gearry, Andrew S. Day & Michael A. Kamm. (2014) Fecal Biomarkers in the Diagnosis and Monitoring of Crohnʼs Disease. Inflammatory Bowel Diseases 20:9, pages 1668-1677.
Crossref
Crossref
Jin-Feng Lin, Jin-Min Chen, Jun-Hua Zuo, Allen Yu, Zhu-Jun Xiao, Fei-Hong Deng, Biao Nie & Bo Jiang. (2014) Meta-analysis. Inflammatory Bowel Diseases 20:8, pages 1407-1415.
Crossref
Crossref
Alexander G.L. Bodelier, Marieke J. Pierik, Tim van den Heuvel, Ingeborg M.J. Bovee-Oudenhoven, Evelien de Boer, Wim Hameeteman, Ad A.M. Masclee & Daisy Jonkers. (2014) Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients. European Journal of Gastroenterology & Hepatology 26:8, pages 902-909.
Crossref
Crossref
James Turvill. (2014) Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy. Frontline Gastroenterology 5:3, pages 167-175.
Crossref
Crossref
Florian Beigel, Matthias Deml, Fabian Schnitzler, Simone Breiteneicher, Burkhard Göke, Thomas Ochsenkühn & Stephan Brand. (2014) Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies. PLoS ONE 9:6, pages e99293.
Crossref
Crossref
Paul Henderson, Niall H Anderson & David C Wilson. (2014) The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 109:5, pages 637-645.
Crossref
Crossref
Phillip Minar, Yael Haberman, Ingrid Jurickova, Ting Wen, Marc E. Rothenberg, Mi-Ok Kim, Shehzad A. Saeed, Robert N. Baldassano, Michael Stephens, James Markowitz, Joel Rosh, Wallace V. Crandall, Melvin B. Heyman, David R. Mack, Anne M. Griffiths, Susan S. Baker, Jeffrey S. Hyams, Subra Kugathasan & Lee A. Denson. (2014) Utility of Neutrophil Fcγ Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
Uri Kopylov, Greg Rosenfeld, Brian Bressler & Ernest Seidman. (2014) Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:4, pages 742-756.
Crossref
Crossref
Edgar S. Wills, Daisy M. A. E. Jonkers, Paul H. Savelkoul, Ad A. Masclee, Marieke J. Pierik & John Penders. (2014) Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation. PLoS ONE 9:3, pages e90981.
Crossref
Crossref
Jean–Frédéric Colombel, Paul J. Rutgeerts, William J. Sandborn, Mei Yang, Anne Camez, Paul F. Pollack, Roopal B. Thakkar, Anne M. Robinson, Naijun Chen, Parvez M. Mulani & Jingdong Chao. (2014) Adalimumab Induces Deep Remission in Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology 12:3, pages 414-422.e5.
Crossref
Crossref
Jesica C. Makanyanga, Doug Pendsé, Nikolaos Dikaios, Stuart Bloom, Sara McCartney, Emma Helbren, Elaine Atkins, Terry Cuthbertson, Shonit Punwani, Alastair Forbes, Steve Halligan & Stuart A. Taylor. (2013) Evaluation of Crohn’s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. European Radiology 24:2, pages 277-287.
Crossref
Crossref
Vito Annese, Marco Daperno, Matthew D. Rutter, Aurelien Amiot, Peter Bossuyt, James East, Marc Ferrante, Martin Götz, Konstantinos H. Katsanos, Ralf Kießlich, Ingrid Ordás, Alessandro Repici, Bruno Rosa, Shaji Sebastian, Torsten Kucharzik & Rami Eliakim. (2013) European evidence based consensus for endoscopy in inflammatory bowel disease. Journal of Crohn's and Colitis 7:12, pages 982-1018.
Crossref
Crossref
Triana Lobatón, Alicia López-García, Francisco Rodríguez-Moranta, Alexandra Ruiz, Lorena Rodríguez & Jordi Guardiola. (2013) A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. Journal of Crohn's and Colitis 7:12, pages e641-e651.
Crossref
Crossref
Gerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, Ken Nally, Laurent Peyrin-Biroulet, Alain Schoepfer, Morten Vatn, Stephan Vavricka & Robert Logan. (2013) Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion. Journal of Crohn's and Colitis 7:8, pages 670-677.
Crossref
Crossref
Robert J. Basseri, Elizabeta Nemeth, Maria E. Vassilaki, Benjamin Basseri, Pedram Enayati, Omid Shaye, Leonidas A. Bourikas, Tom Ganz & Konstantinos A. Papadakis. (2013) Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. Journal of Crohn's and Colitis 7:8, pages e286-e291.
Crossref
Crossref
James D. Falvey, Richard B. Gearry & Andrew S. Day. (2013) Fecal Calprotectin Does Not Predict Endoscopic Remission in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 19:6, pages E80-E81.
Crossref
Crossref
Lars-Petter Jelsness-Jørgensen, Tomm Bernklev & Bjørn Moum. (2013) Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission. Gastroenterology Research and Practice 2013, pages 1-4.
Crossref
Crossref